End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.16 CNY | +0.96% | 0.00% | -5.67% |
25/04 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
11/04 | Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-5.67% | 109.11Cr | |
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr |
- Stock Market
- Equities
- 600664 Stock
- News Harbin Pharmaceutical Group Co., Ltd.
- Harbin Pharmaceutical Group's Cefotiam Hydrochloride Selected for China's Centralized Procurement Bid